Company

Guska

Biotechnology Research Montevideo, Uy 10 employees

Employees: 10
Contacts: 1
Emails: 1

guska.bio LinkedIn

Guska Overview

Headquarters: Montevideo, Uy
Website: guska.bio
Industry: Biotechnology Research
Employees: 10
Founded: 2024
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

oncology therapies oncolytic viruses RNA technology AI-biotech AI-driven viruses

About Guska

Guska develops solutions based on synthetic RNA oncolytic virus therapy that have potent and safe immunostimulatory effects to address the pain point of cancer treatment by providing a targeted and less harmful alternative to traditional therapies. Our technology uses synthetic RNA viruses designed to safely reach and destroy cancer cells without affecting normal cells and promoting a robust immune response against tumor cells.